Inovio Pharmaceuticals Revenue vs. Price To Sales

INO Stock  USD 4.07  0.01  0.25%   
Based on Inovio Pharmaceuticals' profitability indicators, Inovio Pharmaceuticals may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess Inovio Pharmaceuticals' ability to earn profits and add value for shareholders.
 
Total Revenue  
First Reported
1998-12-31
Previous Quarter
100.8 K
Current Value
0.0
Quarterly Volatility
4.4 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, Inovio Pharmaceuticals' Days Sales Outstanding is very stable compared to the past year. As of the 24th of November 2024, Sales General And Administrative To Revenue is likely to grow to 60.05, while Price To Sales Ratio is likely to drop 154.95. At this time, Inovio Pharmaceuticals' Total Other Income Expense Net is very stable compared to the past year. As of the 24th of November 2024, Interest Income is likely to grow to about 8.6 M, though Accumulated Other Comprehensive Income is likely to grow to (629.5 K).
For Inovio Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Inovio Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Inovio Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Inovio Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Inovio Pharmaceuticals over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharmaceuticals. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.43)
Revenue Per Share
0.025
Quarterly Revenue Growth
(0.55)
Return On Assets
(0.40)
Return On Equity
(0.91)
The market value of Inovio Pharmaceuticals is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inovio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Inovio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Inovio Pharmaceuticals Price To Sales vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Inovio Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Inovio Pharmaceuticals value to that of its competitors to determine the firm's financial worth.
Inovio Pharmaceuticals is rated third overall in revenue category among its peers. It is currently regarded as number one stock in price to sales category among its peers . The ratio of Revenue to Price To Sales for Inovio Pharmaceuticals is about  4,636 . At this time, Inovio Pharmaceuticals' Total Revenue is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Inovio Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Inovio Revenue vs. Competition

Inovio Pharmaceuticals is rated third overall in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 991.92 Million. Inovio Pharmaceuticals adds roughly 832,010 in revenue claiming only tiny portion of equities under Health Care industry.

Inovio Price To Sales vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Inovio Pharmaceuticals

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
832.01 K
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Inovio Pharmaceuticals

P/S

 = 

MV Per Share

Revenue Per Share

 = 
179.48 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Inovio Price To Sales Comparison

Inovio Pharmaceuticals is currently under evaluation in price to sales category among its peers.

Inovio Pharmaceuticals Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Inovio Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Inovio Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Inovio Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Inovio Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-662.6 K-629.5 K
Operating Income-135.2 M-128.5 M
Income Before Tax-135.1 M-128.4 M
Total Other Income Expense Net109.3 K114.8 K
Net Loss-135.1 M-128.4 M
Income Tax Expense 2.00  1.90 
Net Loss-164.6 M-172.8 M
Non Operating Income Net Other-1.1 M-1.2 M
Net Loss-251.8 M-239.2 M
Interest Income8.2 M8.6 M
Net Interest Income6.9 M7.3 M
Change To Netincome34.5 M20.1 M
Net Loss(6.09)(6.40)
Income Quality 0.92  0.87 
Net Income Per E B T 1.19  1.13 

Inovio Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Inovio Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Inovio Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Inovio Pharmaceuticals' important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Inovio Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Funds Screener Now

   

Funds Screener

Find actively-traded funds from around the world traded on over 30 global exchanges
All  Next Launch Module

Use Investing Themes to Complement your Inovio Pharmaceuticals position

In addition to having Inovio Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Penny Thematic Idea Now

Penny
Penny Theme
Solid stocks, funds or ETFs with below average market capitalization and typicl daily price below 2. The Penny theme has 56 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Penny Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Inovio Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inovio Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inovio Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inovio Pharmaceuticals Stock:
Check out Risk vs Return Analysis.
To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
To fully project Inovio Pharmaceuticals' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Inovio Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Inovio Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows.
Potential Inovio Pharmaceuticals investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Inovio Pharmaceuticals investors may work on each financial statement separately, they are all related. The changes in Inovio Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Inovio Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.